Benefits and harms in pivotal trials of oral centrally acting antiobesity medicines: A systematic review and meta-analysis.
<h4>Objectives</h4> <p>To evaluate the benefits and harms of oral centrally acting antiobesity medicinal products in pivotal trials.</p> <h4>Methods</h4> <p>The European Medicines Agency and Federal Drug Administration websites, PubMed, and ClinicalTrials....
| Autores principales: | , , , , |
|---|---|
| Formato: | Journal article |
| Lenguaje: | English |
| Publicado: |
Wiley
2018
|
| Materias: |